CC2018: Contemporary Management of Inferior Vena Cava (IVC) Filters
This Panel Session will review the indications for vena cava filter placement in patients with deep vein thrombosis (DVT) and failure of anticoagulation, contraindication to anticoagulation, and prophylaxis in high-risk patients. The course will also review the current status of indications for inferior vena cava (IVC) filter removal. There will be a discussion of the current medico legal climate surrounding the use of IVC filters and their complications.
- Current Indications for IVC Filters
Michael R. Go, MD, FACS, Columbus, OH
- Best Technique for ICV Filter Placement: What to Look For and What to Avoid
John E. Rectenwald, MD, MS, FACS, Madison, WI
- Is There a Role for Prophylactic IVC Filters?
Efthymios Avgerinos, MD, PhD, Pittsburgh, PA
- Long-Term Complication of IVC Filters
David L. Gillespie, MD, RVT, FACS, Dartmouth, MA
- IVC Filter Removal: Is There a Best Technique?
Cassius I. Ochoa Chaar, MD, MS, FACS, Guilford, CT
- Litigation Related to IVC Filters
Anil P. Hingorani, MD, FACS, Brooklyn, NY
- Practicing surgeons
- Apply new knowledge and ideas to improve their surgical practice
- Adapt concepts and quality measures in support of research advancements
- Enhance the quality of patient care
- For questions about the course content, please contact firstname.lastname@example.org.
- If you have any technical questions, contact email@example.com.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website: http://www.accme.org/requirements/accreditation-requirements-cme-providers/policies-and-definitions/financial-relationships-and-conflicts-interest
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.
(Download the full list of disclosures.)
Faculty and Disclosures
Michael R. Go, MD, FACS, Columbus, OH - No Disclosures
John E. Rectenwald, MD, MS, FACS, Madison, WI - No Disclosures
Efthymios Avgerinos, MD, PhD, Pittsburgh, PA - No Disclosures
David L. Gillespie, MD, RVT, FACS, Dartmouth, MA - No Disclosures
Cassius I. Ochoa Chaar, MD, MS, FACS, Guilford, CT - No Disclosures
Anil P. Hingorani, MD, FACS, Brooklyn, NY - No Disclosures
Program Committee and Disclosures
CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - No Disclosures
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - No Disclosures
David C. Borgstrom, MD, FACS, Morgantown, WV - No Disclosures
Daniel L. Dent, MD, FACS, San Antonio, TX - No Disclosures
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Audra A. Duncan, MD, FACS, London, ON - No Disclosures
Mariam F. Eskander, MD, Boston, MA - No Disclosures
Paula Ferrada, MD, FACS, Richmond, VA - No Disclosures
Neil H. Hyman, MD, FACS, Chicago, IL - No Disclosures
Martin S. Karpeh, Jr., MD, FACS, New York, NY - No Disclosures
Dennis H. Kraus, MD, FACS, New York, NY - No Disclosures
Kenneth W. Sharp, MD, FACS, Nashville, TN - No Disclosures
David A. Spain, MD, FACS, Stanford, CA - No Disclosures
Mary T. Hawn, MD, FACS, Stanford, CA - No Disclosures
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - No Disclosures
Barbara Lee Bass, MD, FACS, FRCS(Hon), Houston, TX - No Disclosures
Quan-Yang Duh, MD, FACS, San Francisco, CA - No Disclosures
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - No Disclosures
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - No Disclosures
Valerie W. Rusch, MD, FACS, New York, NY - No Disclosures
Note: Residents will receive a Certificate of Completion.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Self Assessment Credit
- 1.50 Certificate of Completion